OLFM2 (olfactomedin 2)

2014-11-01  

Identity

HGNC
LOCATION
19p13.2
LOCUSID
ALIAS
NOE2,NOELIN2,NOELIN2_V1,OlfC
FUSION GENES

Other Information

Locus ID:

NCBI: 93145
MIM: 617492
HGNC: 17189
Ensembl: ENSG00000105088

Variants:

dbSNP: 93145
ClinVar: 93145
TCGA: ENSG00000105088
COSMIC: OLFM2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000105088ENST00000264833O95897
ENSG00000105088ENST00000590841K7EIS8
ENSG00000105088ENST00000592448K7ELC6
ENSG00000105088ENST00000593091K7EKW2

Expression (GTEx)

0
50
100
150

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
383509022024OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.2
383509022024OLFM2 promotes epithelial-mesenchymal transition, migration, and invasion in colorectal cancer through the TGF-β/Smad signaling pathway.2
369822962023The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.1
369822962023The Role of Olfactomedin 2 in the Adipose Tissue-Liver Axis and Its Implication in Obesity-Associated Nonalcoholic Fatty Liver Disease.1
358064472022New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.2
358064472022New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.2
295538612018Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.3
295538612018Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.3
278441442017Identification and functional characterisation of genetic variants in OLFM2 in children with developmental eye disorders.6
278441442017Identification and functional characterisation of genetic variants in OLFM2 in children with developmental eye disorders.6
252983992014Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cells.23
252983992014Olfactomedin 2, a novel regulator for transforming growth factor-β-induced smooth muscle differentiation of human embryonic stem cell-derived mesenchymal cells.23
171221262006SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma.25
171221262006SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma.25
171221262006SNPs and interaction analyses of noelin 2, myocilin, and optineurin genes in Japanese patients with open-angle glaucoma.25

Citation

Dessen P

OLFM2 (olfactomedin 2)

Atlas Genet Cytogenet Oncol Haematol. 2014-11-01

Online version: http://atlasgeneticsoncology.org/gene/71113/gene-fusions/js/lib/all.min.js